Evaluation of optimal monoenergetic images acquired by dual-energy CT in the diagnosis of T staging of thoracic esophageal cancer

Fanrong Cheng, Yan Liu, Lihong Du, Lei Wang, Lan Li, Jinfang Shi, Xiaoxia Wang, Jiuquan ZhangInsights 2023 · DOI

TL;DR

This study demonstrates that dual-energy CT (DECT) with specific low-keV monoenergetic image (MEI+) reconstructions, particularly in the venous phase, significantly improves the visualization and T-staging accuracy of thoracic esophageal cancer (EC) compared to conventional CT. These findings suggest DECT offers a more precise tool for preoperative staging, crucial for treatment planning.

What Problem Does This Paper Address?

Accurate T-staging of esophageal cancer (EC) is critical for determining the appropriate treatment strategy, with surgery being the primary option for early-stage disease and neoadjuvant chemotherapy followed by surgery for locally advanced cases. Conventional CT, while widely used, struggles with differentiating tumor boundaries and surrounding tissues due to low contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR), leading to a low detection rate for early-stage tumors. Existing advanced imaging techniques like endoscopic ultrasound (EUS) and MRI have their own limitations, such as obstruction issues with EUS and motion artifacts with MRI. This paper addresses the need for a more accurate and reliable non-invasive imaging method for EC T-staging, exploring the potential of DECT-derived monoenergetic images.

Methods

The researchers conducted a retrospective study involving 68 patients with histopathologically confirmed EC who underwent DECT. They reconstructed five different monoenergetic images (MEI+) at 40, 50, 60, 70, and 80 keV, alongside a standard polyenergetic image (PEI). Two radiologists independently assessed lesion conspicuity (subjectively) and quantified contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR) (objectively). They also subjectively evaluated T-staging on both optimal MEI+ and PEI images. Furthermore, multiple quantitative parameters were measured to assess diagnostic performance for differentiating T1-2 from T3-4 stages. Statistical analysis included Wilcoxon tests, Kappa concordance tests, and ROC curve analysis.

Datasets

The study utilized a dataset of 68 patients with thoracic esophageal cancer who underwent DECT scans between September 2019 and December 2020. Of these, 49 patients received radical surgery and had pathologically confirmed T and N staging, serving as the ground truth for comparison. The remaining 19 patients were treated with systemic therapy. No new benchmarks were introduced; the study focused on evaluating existing DECT technology against established staging criteria.

Key Insights and Ideas

  • Low-keV MEI+ is Key: The study strongly suggests that lower keV monoenergetic images (specifically 40 keV) in the venous phase offer superior visualization of EC lesions compared to higher keV MEI+ and conventional PEI. This is attributed to enhanced CNR and SNR.
  • Venous Phase Advantage: The venous phase of contrast enhancement appears to be particularly beneficial for T-staging with DECT, likely due to optimal contrast opacification of the tumor and surrounding structures.
  • Quantitative Parameters Matter: Beyond subjective image quality, DECT's ability to generate multiparametric data (like electron density, Rho) provides valuable quantitative information that aids in differentiating early-stage from advanced-stage EC.
  • Rho as a Strong Predictor: The electron density (Rho) parameter, especially in the venous phase, demonstrated excellent diagnostic efficiency in distinguishing T1-2 from T3-4 stages, highlighting its potential as a quantitative biomarker.

Key Results

  • Subjective Improvement: MEI+ images, particularly at 40 keV in the venous phase, received higher subjective ratings for lesion margin delineation and lesion inside assessment compared to PEI.
  • Objective Enhancement: MEI+ images showed significantly higher SNR and CNR compared to PEI (p<0.05). The highest SNR was observed at 50 keV (arterial phase) and 40 keV (venous phase), while CNR peaked at 40 keV in the venous phase.
  • T-Staging Accuracy: The agreement between MEI+ 40 keV (venous phase) and pathological T categories was 81.63% (40/49), significantly higher than the 48.97% (24/49) agreement with PEI.
  • Diagnostic Efficiency: ROC curve analysis revealed that Rho in the venous phase had excellent diagnostic efficiency for identifying T1-2 from T3-4 stages, with an AUC of 0.84.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design and Small Sample Size: The study was retrospective, and the sample size was relatively small. They recommend larger, prospective studies to validate their findings.
  • Lymph Node Staging Not Assessed: The study did not assess lymph node status, which is crucial for overall TNM staging. Future research could focus on preoperative lymph node staging using DECT.
  • Comparison with MRI: The study did not directly compare DECT with magnetic resonance imaging (MRI), another important modality for EC staging.

Future work should focus on addressing these limitations, particularly by conducting prospective studies and exploring the combined utility of DECT with other advanced imaging techniques.

Summary updated

Abstract

MEI (+) reconstructions at low keV in the venous phase improved the assessment of lesion conspicuity and also have great potential for preoperative assessment of T staging in patients with EC.
BibTeX
@inproceedings{cheng2023evaluation,
  author = {Fanrong Cheng and Yan Liu and Lihong Du and Lei Wang and Lan Li and Jinfang Shi and Xiaoxia Wang and Jiuquan Zhang},
  title = {{Evaluation of optimal monoenergetic images acquired by dual-energy CT in the diagnosis of T staging of thoracic esophageal cancer}},
  booktitle = {Insights},
  year = {2023},
  doi = {10.1186/s13244-023-01381-1},
}
Figure